Vascular endothelin receptor type B: Structure, function and dysregulation in vascular disease

Biochemical Pharmacology

Volumn 84, Issue 2, 2012, Pages 147-162

  Mazzuca, Marc Q ^a   Khalil, Raouf A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Blood pressure; Calcium; Endothelium; Hypertension; Smooth muscle

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; AMBRISENTAN; ATRIAL NATRIURETIC FACTOR; BOSENTAN; DARUSENTAN; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 1 [11-21]; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; NITRIC OXIDE; PROSTACYCLIN; PROTEIN KINASE C; RYANODINE; SARAFOTOXIN S6C; SITAXSENTAN; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; THAPSIGARGIN;

ATHEROSCLEROSIS; BRAIN ISCHEMIA; CELL GROWTH; CELL SURFACE; CORONARY ARTERY DISEASE; DIMERIZATION; DRUG POTENCY; ENDOCYTOSIS; GENETIC DISORDER; GENETIC TRANSCRIPTION; HIRSCHSPRUNG DISEASE; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOXIA; KIDNEY CIRCULATION; LIGAND BINDING; LUNG CIRCULATION; MOLECULAR WEIGHT; MUSCLE CONTRACTION; NONHUMAN; PALMITOYLATION; PHENOTYPE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SYSTEMIC CIRCULATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASCULITIS;

EID: 84861227481     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.03.020     Document Type: Note

References (142)

1. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
2. T. Sakurai, M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, and K. Goto Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature 348 1990 732 735
3. E.L. Schiffrin, and R.M. Touyz Vascular biology of endothelin J Cardiovasc Pharmacol 32 Suppl. 3 1998 S2 S13
4. T.F. Luscher, and M. Barton Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs Circulation 102 2000 2434 2440
5. F.D. Russell, J.N. Skepper, and A.P. Davenport Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme Circ Res 83 1998 314 321
6. C.J. Lowenstein, C.N. Morrell, and M. Yamakuchi Regulation of Weibel-Palade body exocytosis Trends Cardiovasc Med 15 2005 302 308
7. M.M. Hynynen, and R.A. Khalil The vascular endothelin system in hypertension - recent patents and discoveries Recent Pat Cardiovasc Drug Discov 1 2006 95 108
8. B.Y. Kang, J.M. Kleinhenz, T.C. Murphy, and C.M. Hart The PPARgamma ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo Am J Physiol Lung Cell Mol Physiol 301 2011 L881 L891
9. J. Luo, J. Martinez, X. Yin, A. Sanchez, D. Tripathy, and P. Grammas Hypoxia induces angiogenic factors in brain microvascular endothelial cells Microvasc Res 83 2012 138 145
10. T.S. Elton, S. Oparil, G.R. Taylor, P.H. Hicks, R.H. Yang, and H. Jin Normobaric hypoxia stimulates endothelin-1 gene expression in the rat Am J Physiol 263 1992 R1260 R1264
11. R.M. Kedzierski, and M. Yanagisawa Endothelin system: the double-edged sword in health and disease Annu Rev Pharmacol Toxicol 41 2001 851 876
12. J. Dupuis, J.F. Jasmin, S. Prie, and P. Cernacek Importance of local production of endothelin-1 and of the ET(B)receptor in the regulation of pulmonary vascular tone Pulm Pharmacol Ther 13 2000 135 140
13. T. Fukuroda, T. Fujikawa, S. Ozaki, K. Ishikawa, M. Yano, and M. Nishikibe Clearance of circulating endothelin-1 by ETB receptors in rats Biochem Biophys Res Commun 199 1994 1461 1465
14. C.E. Gariepy, T. Ohuchi, S.C. Williams, J.A. Richardson, and M. Yanagisawa Salt-sensitive hypertension in endothelin-B receptor-deficient rats J Clin Invest 105 2000 925 933
15. S.J. Shi, H. Rakugi, K. Higashimori, B.B. Jiang, J. Higaki, and H. Mikami Augmentation by converting enzyme inhibition of accelerated endothelin release from rat mesenteric arteries following nephrectomy Biochem Biophys Res Commun 202 1994 246 251
16. A.P. Davenport International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature Pharmacol Rev 54 2002 219 226
17. A. Sakamoto, M. Yanagisawa, T. Sawamura, T. Enoki, T. Ohtani, and T. Sakurai Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists J Biol Chem 268 1993 8547 8553
18. C. Stannard, P. Lehenkari, and J. Godovac-Zimmermann Functional diversity of endothelin pathways in human lung fibroblasts may be based on structural diversity of the endothelin receptors Biochemistry 42 2003 13909 13918
19. Y. Okamoto, H. Ninomiya, M. Tanioka, A. Sakamoto, S. Miwa, and T. Masaki Palmitoylation of human endothelinB. Its critical role in G protein coupling and a differential requirement for the cytoplasmic tail by G protein subtypes J Biol Chem 272 1997 21589 21596
20. S.L. Belmonte, and B.C. Blaxall G protein coupled receptor kinases as therapeutic targets in cardiovascular disease Circ Res 109 2011 309 319
21. V. Shyamala, T.H. Moulthrop, J. Stratton-Thomas, and P. Tekamp-Olson Two distinct human endothelin B receptors generated by alternative splicing from a single gene Cell Mol Biol Res 40 1994 285 296
22. N.A. Elshourbagy, J.E. Adamou, A.W. Gagnon, H.L. Wu, M. Pullen, and P. Nambi Molecular characterization of a novel human endothelin receptor splice variant J Biol Chem 271 1996 25300 25307
23. M. Tsutsumi, G. Liang, and P.A. Jones Novel endothelin B receptor transcripts with the potential of generating a new receptor Gene 228 1999 43 49
24. J.G. De Mey, M.G. Compeer, P. Lemkens, and M.J. Meens ETA-receptor antagonists or allosteric modulators Trends Pharmacol Sci 32 2011 345 351
25. J.D. Paasche, T. Attramadal, C. Sandberg, H.K. Johansen, and H. Attramadal Mechanisms of endothelin receptor subtype-specific targeting to distinct intracellular trafficking pathways J Biol Chem 276 2001 34041 34050
26. A. Oksche, G. Boese, A. Horstmeyer, J. Furkert, M. Beyermann, and M. Bienert Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor Mol Pharmacol 57 2000 1104 1113
27. J.D. Paasche, T. Attramadal, K. Kristiansen, M.P. Oksvold, H.K. Johansen, and H.S. Huitfeldt Subtype-specific sorting of the ETA endothelin receptor by a novel endocytic recycling signal for G protein-coupled receptors Mol Pharmacol 67 2005 1581 1590
28. M.P. Schneider, E.I. Boesen, and D.M. Pollock Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease Annu Rev Pharmacol Toxicol 47 2007 731 759
29. B. Gregan, J. Jurgensen, G. Papsdorf, J. Furkert, M. Schaefer, and M. Beyermann Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers J Biol Chem 279 2004 27679 27687
30. S.W. Watts Endothelin receptors: what's new and what do we need to know Am J Physiol Regul Integr Comp Physiol 298 2010 R254 R260
31. R.M. Rapoport, and M. Zuccarello Endothelin (A)-endothelin (B) receptor cross-talk and endothelin receptor binding J Pharm Pharmacol 63 2011 1373 1377
32. S. Yoon, M. Zuccarello, and R.M. Rapoport Endothelin (A)-endothelin (B) receptor cross-talk in rat basilar artery in situ Naunyn Schmiedebergs Arch Pharmacol 2012
33. E.I. Boesen Endothelin ETB receptor heterodimerization: beyond the ETA receptor Kidney Int 74 2008 693 694
34. Y. Zhang, C. Fu, H. Ren, D. He, X. Wang, and L.D. Asico Impaired stimulatory effect of ETB receptor on D receptor in immortalized renal proximal tubule cells of spontaneously hypertensive rats Kidney Blood Press Res 34 2011 75 82
35. C. Zeng, U. Hopfer, L.D. Asico, G.M. Eisner, R.A. Felder, and P.A. Jose Altered AT1 receptor regulation of ETB receptors in renal proximal tubule cells of spontaneously hypertensive rats Hypertension 46 2005 926 931
36. R. Boyd, M.T. Ratsep, L.L. Ding, and H.D. Wang ETA and ETB receptors are expressed in vascular adventitial fibroblasts Am J Physiol Heart Circ Physiol 301 2011 H2271 H2278
37. G. Bkaily, L. Avedanian, J. Al-Khoury, C. Provost, M. Nader, and P. D'Orleans-Juste Nuclear membrane receptors for ET-1 in cardiovascular function Am J Physiol Regul Integr Comp Physiol 300 2011 R251 R263
38. P. D'Orleans-Juste, J. Labonte, G. Bkaily, S. Choufani, M. Plante, and J.C. Honore Function of the endothelin (B) receptor in cardiovascular physiology and pathophysiology Pharmacol Ther 95 2002 221 238
39. C.R. Tirapelli, D.A. Casolari, A. Yogi, A.C. Montezano, R.C. Tostes, and E. Legros Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation Br J Pharmacol 146 2005 903 912
40. M. Yanagisawa, H. Kurihara, S. Kimura, K. Goto, and T. Masaki A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels J Hypertens Suppl 6 1988 S188 S191
41. S.K. Fellner, and W.J. Arendshorst Endothelin A and B receptors of preglomerular vascular smooth muscle cells Kidney Int 65 2004 1810 1817
42. E.A. Ko, W.S. Park, J.H. Ko, J. Han, N. Kim, and Y.E. Earm Endothelin-1 increases intracellular Ca(2+) in rabbit pulmonary artery smooth muscle cells through phospholipase C Am J Physiol Heart Circ Physiol 289 2005 H1551 H1559
43. D.M. Pollock, J.M. Jenkins, A.K. Cook, J.D. Imig, and E.W. Inscho L-type calcium channels in the renal microcirculatory response to endothelin Am J Physiol Renal Physiol 288 2005 F771 F777
44. E. Hersch, J. Huang, J.R. Grider, and K.S. Murthy Gq/G13 signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB Am J Physiol Cell Physiol 287 2004 C1209 C1218
45. M. Henriksson, P. Vikman, E. Stenman, S. Beg, and L. Edvinsson Inhibition of PKC activity blocks the increase of ETB receptor expression in cerebral arteries BMC Pharmacol 6 2006 13
46. E. Uddman, M. Henriksson, K. Eskesen, and L. Edvinsson Role of mitogen-activated protein kinases in endothelin ETB receptor up-regulation after organ culture of rat mesenteric artery Eur J Pharmacol 482 2003 39 47
47. D. Nilsson, A. Wackenfors, L. Gustafsson, M. Ugander, R. Ingemansson, and L. Edvinsson PKC and MAPK signalling pathways regulate vascular endothelin receptor expression Eur J Pharmacol 580 2008 190 200
48. T. Higa, T. Horinouchi, H. Aoyagi, H. Asano, T. Nishiya, and A. Nishimoto Endothelin type B receptor-induced sustained Ca2+ influx involves G(q/11)/phospholipase C-independent, p38 mitogen-activated protein kinase-dependent activation of Na+/H+ exchanger J Pharmacol Sci 113 2010 276 280
49. A. Sanchez-Mejias, R.M. Fernandez, M. Lopez-Alonso, G. Antinolo, and S. Borrego New roles of EDNRB and EDN3 in the pathogenesis of Hirschsprung disease Genet Med 12 2010 39 43
50. H. Tanaka, K. Moroi, J. Iwai, H. Takahashi, N. Ohnuma, and S. Hori Novel mutations of the endothelin B receptor gene in patients with Hirschsprung's disease and their characterization J Biol Chem 273 1998 11378 11383
51. P.M. Rose, S.R. Krystek Jr., P.S. Patel, E.C. Liu, J.S. Lynch, and D.A. Lach Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors FEBS Lett 361 1995 243 249
52. T. Yamada, S. Ohtani, T. Sakurai, T. Tsuji, T. Kunieda, and M. Yanagisawa Reduced expression of the endothelin receptor type B gene in piebald mice caused by insertion of a retroposon-like element in intron 1 J Biol Chem 281 2006 10799 10807
53. K. Hosoda, R.E. Hammer, J.A. Richardson, A.G. Baynash, J.C. Cheung, and A. Giaid Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice Cell 79 1994 1267 1276
54. T. Ohuchi, T. Kuwaki, G.Y. Ling, D. Dewit, K.H. Ju, and M. Onodera Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice Am J Physiol 276 1999 R1071 R1077
55. T. Quaschning, B. Rebhan, C. Wunderlich, C. Wanner, C.M. Richter, and T. Pfab Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading J Hypertens 23 2005 979 985
56. A.J. Bagnall, N.F. Kelland, F. Gulliver-Sloan, A.P. Davenport, G.A. Gray, and M. Yanagisawa Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt Hypertension 48 2006 286 293
57. S.W. Leung, S.L. Lim, C.C. Pang, and R.Y. Man Use of A-192621 and IRL-2500 to unmask the mesenteric and renal vasodilator role of endothelin ET(B) receptors J Cardiovasc Pharmacol 39 2002 533 543
58. L. McMurdo, R. Corder, C. Thiemermann, and J.R. Vane Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor Br J Pharmacol 108 1993 557 561
59. S.M. Gardiner, P.A. Kemp, J.E. March, and T. Bennett Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats Br J Pharmacol 112 1994 823 830
60. D.L. Williams Jr., K.L. Jones, D.J. Pettibone, E.V. Lis, and B.V. Clineschmidt Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes Biochem Biophys Res Commun 175 1991 556 561
61. M. Clozel, and V. Breu The role of ETB receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443 FEBS Lett 383 1996 42 45
62. J.P. Gratton, G.A. Rae, G. Bkaily, and P. D'Orleans-Juste ET(B) receptor blockade potentiates the pressor response to big endothelin-1 but not big endothelin-2 in the anesthetized rabbit Hypertension 35 2000 726 731
63. F.E. Strachan, J.C. Spratt, I.B. Wilkinson, N.R. Johnston, G.A. Gray, and D.J. Webb Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men Hypertension 33 1999 581 585
64. J.C. Spratt, J. Goddard, N. Patel, F.E. Strachan, A.J. Rankin, and D.J. Webb Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men Br J Pharmacol 134 2001 648 654
65. M. Adner, G.G. Geary, and L. Edvinsson Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture Acta Physiol Scand 163 1998 121 129
66. J.P. Zheng, Y. Zhang, L. Edvinsson, T. Hjalt, and C.B. Xu NF-kappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries Eur J Pharmacol 637 2010 148 154
67. I. Lindstedt, C.B. Xu, Y. Zhang, and L. Edvinsson Increased perfusion pressure enhances the expression of endothelin (ETB) and angiotensin II (AT1, AT2) receptors in rat mesenteric artery smooth muscle cells Blood Press 18 2009 78 85
68. M. Cattaruzza, C. Dimigen, H. Ehrenreich, and M. Hecker Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells FASEB J 14 2000 991 998
69. M.C. Verhaar, F.E. Strachan, D.E. Newby, N.L. Cruden, H.A. Koomans, and T.J. Rabelink Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade Circulation 97 1998 752 756
70. W.G. Haynes, F.E. Strachan, and D.J. Webb Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo Circulation 92 1995 357 363
71. G.W. He, M.H. Liu, Q. Yang, A. Furnary, and A.P. Yim Role of endothelin-1 receptor antagonists in vasoconstriction mediated by endothelin and other vasoconstrictors in human internal mammary artery Ann Thorac Surg 84 2007 1522 1527
72. N.R. Tykocki, C.E. Gariepy, and S.W. Watts Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein J Pharmacol Exp Ther 329 2009 875 881
73. D.G. White, H. Garratt, J.W. Mundin, M.J. Sumner, P.J. Vallance, and I.S. Watts Human saphenous vein contains both endothelin ETA and ETB contractile receptors Eur J Pharmacol 257 1994 307 310
74. S. Moreland, D.M. McMullen, C.L. Delaney, V.G. Lee, and J.T. Hunt Venous smooth muscle contains vasoconstrictor ETB-like receptors Biochem Biophys Res Commun 184 1992 100 106
75. R.J. Johnson, G.D. Fink, S.W. Watts, and J.J. Galligan Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats J Hypertens 20 2002 665 676
76. S.W. Watts, G.D. Fink, C.A. Northcott, and J.J. Galligan Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists Br J Pharmacol 137 2002 69 79
77. E.L. Schiffrin Vascular endothelin in hypertension Vascul Pharmacol 43 2005 19 29
78. P.A. Modesti, I. Cecioni, A. Costoli, L. Poggesi, G. Galanti, and G.G. Serneri Renal endothelin in heart failure and its relation to sodium excretion Am Heart J 140 2000 617 622
79. H. Zhao, I.G. Joshua, and J.P. Porter Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats Am J Hypertens 13 2000 819 826
80. J.B. Giardina, G.M. Green, A.N. Rinewalt, J.P. Granger, and R.A. Khalil Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet Hypertension 37 2001 516 523
81. J.C. Honore, M.H. Fecteau, I. Brochu, J. Labonte, G. Bkaily, and P. D'Orleans-Juste Concomitant antagonism of endothelial and vascular smooth muscle cell ETB receptors for endothelin induces hypertension in the hamster Am J Physiol Heart Circ Physiol 289 2005 H1258 H1264
82. J. Schildroth, J. Rettig-Zimmermann, P. Kalk, A. Steege, M. Fahling, and M. Sendeski Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice Nephrol Dial Transplant 26 2011 779 789
83. D.E. Kohan, N.F. Rossi, E.W. Inscho, and D.M. Pollock Regulation of blood pressure and salt homeostasis by endothelin Physiol Rev 91 2011 1 77
84. J.S. Speed, E.M. George, M. Arany, K. Cockrell, and J.P. Granger Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade PLoS One 6 2011 e26063
85. T.A. Taylor, C.E. Gariepy, D.M. Pollock, and J.S. Pollock Gender differences in ET and NOS systems in ETB receptor-deficient rats: effect of a high salt diet Hypertension 41 2003 657 662
86. Y. Ge, A. Bagnall, P.K. Stricklett, K. Strait, D.J. Webb, and Y. Kotelevtsev Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention Am J Physiol Renal Physiol 291 2006 F1274 F1280
87. J.M. Williams, J.S. Pollock, and D.M. Pollock Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet Hypertension 44 2004 770 775
88. Y. Matsumura, N. Hashimoto, S. Taira, T. Kuro, R. Kitano, and M. Ohkita Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats Hypertension 33 1999 759 765
89. G.L. Bakris, L.H. Lindholm, H.R. Black, H. Krum, S. Linas, and J.V. Linseman Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial Hypertension 56 2010 824 830
90. M. Burnier, and V. Forni Endothelin receptor antagonists: a place in the management of essential hypertension Nephrol Dial Transplant 27 2012 865 868
91. F. Liang, S. Yang, L. Yao, L. Belardinelli, and J. Shryock Ambrisentan and tadalafil synergistically relax endothelin-induced contraction of rat pulmonary arteries Hypertension 59 2012 705 711
92. K. Sato, M. Oka, K. Hasunuma, M. Ohnishi, and S. Kira Effects of separate and combined ETA and ETB blockade on ET-1-induced constriction in perfused rat lungs Am J Physiol 269 1995 L668 L672
93. D.M. LaDouceur, M.A. Flynn, J.A. Keiser, E. Reynolds, and S.J. Haleen ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction Biochem Biophys Res Commun 196 1993 209 215
94. N. Davie, S.J. Haleen, P.D. Upton, J.M. Polak, M.H. Yacoub, and N.W. Morrell ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells Am J Respir Crit Care Med 165 2002 398 405
95. A. Giaid, M. Yanagisawa, D. Langleben, R.P. Michel, R. Levy, and H. Shennib Expression of endothelin-1 in the lungs of patients with pulmonary hypertension N Engl J Med 328 1993 1732 1739
96. M. Muramatsu, M. Oka, Y. Morio, S. Soma, H. Takahashi, and Y. Fukuchi Chronic hypoxia augments endothelin-B receptor-mediated vasodilation in isolated perfused rat lungs Am J Physiol 276 1999 L358 L364
97. D.D. Ivy, T.A. Parker, and S.H. Abman Prolonged endothelin B receptor blockade causes pulmonary hypertension in the ovine fetus Am J Physiol Lung Cell Mol Physiol 279 2000 L758 L765
98. D.D. Ivy, I.F. McMurtry, K. Colvin, M. Imamura, M. Oka, and D.S. Lee Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension Circulation 111 2005 2988 2996
99. S. Sakai, T. Miyauchi, J. Hara, K. Goto, and I. Yamaguchi Hypotensive effect of endothelin-1 via endothelin-B-receptor pathway on pulmonary circulation is enhanced in rats with pulmonary hypertension J Cardiovasc Pharmacol 36 2000 S95 S98
100. M.G. Perry, M.M. Molero, A.D. Giulumian, P.V. Katakam, J.S. Pollock, and D.M. Pollock ET(B) receptor-deficient rats exhibit reduced contraction to ET-1 despite an increase in ET(A) receptors Am J Physiol Heart Circ Physiol 281 2001 H2680 H2686
101. M. Okada, C. Yamashita, and K. Okada Role of endothelin-1 in beagles with dehydromonocrotaline-induced pulmonary hypertension Circulation 92 1995 114 119
102. S.M. Black, E. Mata-Greenwood, R.W. Dettman, B. Ovadia, R.K. Fitzgerald, and O. Reinhartz Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow Circulation 108 2003 1646 1654
103. D.F. Meoli, and R.J. White Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase Can J Physiol Pharmacol 88 2010 830 839
104. D.S. O'Callaghan, L. Savale, D. Montani, X. Jais, O. Sitbon, and G. Simonneau Treatment of pulmonary arterial hypertension with targeted therapies Nat Rev Cardiol 8 2011 526 538
105. C.F. Opitz, R. Ewert, W. Kirch, and D. Pittrow Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter Eur Heart J 29 2008 1936 1948
106. B. Battistini, N. Berthiaume, N.F. Kelland, D.J. Webb, and D.E. Kohan Profile of past and current clinical trials involving endothelin receptor antagonists: the novel -sentan class of drug Exp Biol Med (Maywood) 231 2006 653 695
107. G. Sutsch, W. Kiowski, X.W. Yan, P. Hunziker, S. Christen, and W. Strobel Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure Circulation 98 1998 2262 2268
108. P.R. Kalra, J.C. Moon, and A.J. Coats Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure Int J Cardiol 85 2002 195 197
109. E. Kaluski, I. Kobrin, R. Zimlichman, A. Marmor, O. Krakov, and O. Milo RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study J Am Coll Cardiol 41 2003 204 210
110. N.F. Kelland, and D.J. Webb Clinical trials of endothelin antagonists in heart failure: publication is good for the public health Heart 93 2007 2 4
111. F. Brunner, C. Bras-Silva, A.S. Cerdeira, and A.F. Leite-Moreira Cardiovascular endothelins: essential regulators of cardiovascular homeostasis Pharmacol Ther 111 2006 508 531
112. J.R. Teerlink, V. Breu, U. Sprecher, M. Clozel, and J.P. Clozel Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries Circ Res 74 1994 105 114
113. A. Wackenfors, M. Emilson, R. Ingemansson, T. Hortobagyi, D. Szok, and J. Tajti Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteries Eur J Pharmacol 484 2004 103 109
114. J. Feng, Y. Liu, K.R. Khabbaz, R. Hagberg, N.R. Sodha, and R.M. Osipov Endothelin-1-induced contractile responses of human coronary arterioles via endothelin-A receptors and PKC-alpha signaling pathways Surgery 147 2010 798 804
115. B. Climent, N. Fernandez, E. Sanz, A. Sanchez, L. Monge, and A.L. Garcia-Villalon Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids Eur J Pharmacol 524 2005 102 110
116. G.F. Skovsted, A.F. Pedersen, R. Larsen, M. Sheykhzade, and L. Edvinsson Rapid functional upregulation of vasocontractile endothelin ET(B) receptors in rat coronary arteries Life Sci 2012
117. E. Johnsson, A. Maddahi, A. Wackenfors, and L. Edvinsson Enhanced expression of contractile endothelin ET(B) receptors in rat coronary artery after organ culture Eur J Pharmacol 582 2008 94 101
118. L. Jie, C. Yong-Xiao, Y. Zu-Yi, and X. Cang-Bao Minimally modified LDL upregulates endothelin type B receptors in rat coronary artery via ERK1/2 MAPK and NF-kappaB pathways Biochim Biophys Acta 1821 2011 582 589
119. R.R. Wenzel, M. Fleisch, S. Shaw, G. Noll, U. Kaufmann, and R. Schmitt Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease Circulation 98 1998 2235 2240
120. I. Dimitrijevic, U. Ekelund, M.L. Edvinsson, and L. Edvinsson Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome Heart Vessels 24 2009 393 398
121. D. Szok, J. Hansen-Schwartz, and L. Edvinsson In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery Neurosci Lett 314 2001 69 72
122. M. Henriksson, E. Stenman, and L. Edvinsson Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat Stroke 34 2003 1479 1483
123. H. Ahnstedt, H. Saveland, O. Nilsson, and L. Edvinsson Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK- sensitive signaling pathway BMC Neurosci 12 2011 5
124. H. Ahnstedt, E. Stenman, L. Cao, M. Henriksson, and L. Edvinsson Cytokines and growth factors modify the upregulation of contractile endothelin ET(A) and ET(B) receptors in rat cerebral arteries after organ culture Acta Physiol (Oxf) 2011
125. J. Li, Y.X. Cao, Y. Liu, and C.B. Xu Minimally modified LDL upregulates endothelin type B receptors in rat basilar artery Microvasc Res 83 2011 178 184
126. M.G. Leonard, S. Briyal, and A. Gulati Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats Brain Res 1420 2011 48 58
127. C.W. Washington, and G.J. Zipfel Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature Neurocrit Care 15 2011 312 317
128. P.H. Dagassan, V. Breu, M. Clozel, A. Kunzli, P. Vogt, and M. Turina Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries J Cardiovasc Pharmacol 27 1996 147 153
129. S. Iwasa, J. Fan, T. Shimokama, M. Nagata, and T. Watanabe Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis Atherosclerosis 146 1999 93 100
130. J. Pernow, F. Bohm, B.L. Johansson, U. Hedin, and L. Ryden Enhanced vasoconstrictor response to endothelin-B-receptor stimulation in patients with atherosclerosis J Cardiovasc Pharmacol 36 2000 S418 S420
131. F. Bohm, G. Ahlborg, B.L. Johansson, L.O. Hansson, and J. Pernow Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis Arterioscler Thromb Vasc Biol 22 2002 674 679
132. T. Kobayashi, T. Miyauchi, S. Iwasa, S. Sakai, J. Fan, and M. Nagata Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis Pathol Int 50 2000 929 936
133. J.P. Halcox, K.R. Nour, G. Zalos, and A.A. Quyyumi Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B Hypertension 49 2007 1134 1141
134. N. Murakoshi, T. Miyauchi, Y. Kakinuma, T. Ohuchi, K. Goto, and M. Yanagisawa Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice Circulation 106 2002 1991 1998
135. J.C. Sullivan, J.S. Pollock, and D.M. Pollock Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats Exp Biol Med (Maywood) 231 2006 818 823
136. K. Kitada, N. Yui, M. Koyama, K. Kimura, R. Suzuki, and R. Tanaka Endothelin ETB receptor is involved in sex differences in the development of balloon injury-induced neointimal formation J Pharmacol Exp Ther 336 2011 533 539
137. L.G. Thaete, and M.G. Neerhof Endothelin and blood pressure regulation in the female rat: studies in normal pregnancy and with nitric oxide synthase inhibition-induced hypertension Hypertens Pregnancy 19 2000 233 247
138. K.P. Conrad Maternal vasodilation in pregnancy: the emerging role of relaxin Am J Physiol Regul Integr Comp Physiol 301 2011 R267 R275
139. E.M. George, A.C. Palei, and J.P. Granger Endothelin as a final common pathway in the pathophysiology of preeclampsia: therapeutic implications Curr Opin Nephrol Hypertens 21 2012 157 162
140. A.S. Loria, G. D'Angelo, D.M. Pollock, and J.S. Pollock Early life stress downregulates endothelin receptor expression and enhances acute stress-mediated blood pressure responses in adult rats Am J Physiol Regul Integr Comp Physiol 299 2010 R185 R191
141. M. Kakoki, Y. Hirata, H. Hayakawa, A. Tojo, D. Nagata, and E. Suzuki Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney Circulation 99 1999 1242 1248
142. Y. Fujitani, H. Ueda, T. Okada, Y. Urade, and H. Karaki A selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta J Pharmacol Exp Ther 267 1993 683 689